UNIVERSITY OF THE FUTURE
SCIENTIFICALLY INTRODUCING UNIVERSALITY TO THE UNIVERSITY
peter huebner • micro music laboratories
M E D I C A L   R E S O N A N C E   T H E R A P Y   M U S I C®
R E D U C T I O N   O F   P S Y C H O – P H Y S I O L O G I C A L   M A N I F E S T A T I O N S   O F   S T R E S S

Home

Site Map

Motto

The Cosmic
Education Program

Introduction

Peter Hübner
Developer of the University

 

Faculty of
MEDICAL SCIENCES

Leading Thoughts

Logical Path - Theory

Logical Path - Practice

CURRICULUM

Theoretical Fundamentals

Medical Music
Preparations on CD

Scientific Research

Research Fields in Detail

Pediatrics

Process Stabilization

Hemorrhaging

Immune Status

Infantile Hearing Organ

Blood Pressure

Heart Frequency

Tranquilizers

Hemodynamic

 

 

Astronomy of Mind EQ x IQ

Hall of Harmony

International Experts

Educational Program
Health

Scientific Research

International Media

International Congresses

Membership

Application to the University

 

 






Improved Immune Status in Children with Hearing Abnormalities and Suffering from Radiation Sickness
Under investigation were 44 children with ra­dia­tion sickness at the age of 4-14 years with pathologies of the ear – developed from sup­pu­ra­tive otitis media, chronic secretory otitis media as well as tubal disorders and chronic exsudative otitis media.

The children were treated with MRT-Music® for 8-12 days, each day 1 or 2 times per cd and headphones. Listening time was not limited and depended on the wish of the children.

For the children below six years of age the treatment time averaged 30 minutes, most of the children at the age 13 / 14 years wanted to listen to the whole piece (70 minutes). Next to the treatment with MRT-Music® the children received different vitamin b’s, spasmolytica, disinfecting preparations and biostimulators.

Before the treatment the immunogram of the children showed humoral disorders. Two weeks after the treatment the immunogram of 25% of the patients was normal. Normalization re­garded the AMG-factor, cellular immunity and the t- and b-lymphocytes. In the rest of the pa­tients immune status improved clearly.



 

Investigators:

Dr. med. Elena Merkulowa